$1.63
Value $974M
MPT and SPG stock compared: price, dividend, valuation and results, from SEC filings.
$1.63
Value $974M
$231.38
Value $75.5B
Medical Properties Trust (MPT) has a market value of $974M and Simon Property (SPG) $75.5B. Over the last year, with dividends, MPT moved -65.7% and SPG +33.7%. Dividend yield: MPT 22.09%, SPG 3.85%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
MPT$974M
SPG$75.5B
SPG is 78 times MPT
Revenue, 12 months
MPT$1.0B
SPG$7.2B
SPG is 7.0 times MPT
Net income, 12 months
MPT-$30M
SPG$4.5B
Operating margin
MPT–
SPG45.9%
ROIC
MPT-0.2%
SPG8.1%
8.3 points apart
P/E
MPT–
SPG16.7
Dividend yield
MPT22.1%
SPG3.9%
18.2 points apart
5-year return
MPT-88.4%
SPG+80.3%
168.7 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
MPT-88.4%
SPG+80.3%
| Period | MPTWith dividends | SPGWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | -65.7%Price -68.3% | +33.7%Price +27.8% |
| 3 years since November 17, 2023 | -54.2%-22.9% a yearPrice -64.6% | +120.2%+30.1% a yearPrice +90.2% |
| 5 years since November 17, 2021 | -88.4%-35.0% a yearPrice -92.5% | +80.3%+12.5% a yearPrice +38.1% |
| 10 years since November 18, 2016 | -72.0%-11.9% a yearPrice -86.7% | +113.2%+7.9% a yearPrice +28.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
MPTMedical Properties TrustSPGSimon Property
| Price | $1.63 | $231.38 |
|---|---|---|
| Market value | $974M | $75.5B |
| Enterprise value (EV) | $10.3B | $103B |
| P/E | – | 16.7 |
| P/E, 5-year median | – | 20.4 |
| P/B | 0.2 | 18.7 |
| EV/EBIT | – | 31.5 |
| Free cash flow yield | – | 4.4% |
| Revenue, 12 months | $1.0B | $7.2B |
|---|---|---|
| Net income, 12 months | -$30M | $4.5B |
| Free cash flow, 12 months | – | $3.4B |
| Earnings per share, 12 months | -$0.06 | $13.86 |
| Revenue growth, year on year | -2.4% | 6.7% |
| Revenue growth a year, past | -4.9%over 5 years | +6.7%over 5 years |
| EPS growth a year, past | – | +31.6%over 5 years |
| Gross margin | 89.6% | – |
|---|---|---|
| Operating margin | – | 45.9% |
| Net margin | -3.0% | 63.0% |
| ROIC | -0.2% | 8.1% |
| ROE | -0.7% | 107.7% |
| Cash | $397M | $570M |
|---|---|---|
| Total debt | $9.7B | $29.1B |
| Net debt / EBITDA | 38.7 | 5.9 |
| Interest cover | -0.1× | 2.9× |
| Dividend yield | 22.1% | 3.9% |
|---|---|---|
| Dividend per share, 12 months | $0.36 | $8.90 |
| Dividend growth a year, past | – | +7.3%over 5 years |
| Buyback yield | 2.4% | 0.3% |
| Shareholder yield | 24.5% | 4.2% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Simon Property ($75.5B) is about 77.5 times Medical Properties Trust ($974M), at today's prices.
Since November 18, 2016, MPT's price moved -86.7% and SPG's +28.0%. With dividends: MPT -72.0% (-11.9% a year), SPG +113.2% (+7.9% a year). Past returns do not predict future ones.
The dividend yield at today's price is 22.09% for Medical Properties Trust and 3.85% for Simon Property. Over the last twelve months they paid $0.36 and $8.90 per share.
Over the last twelve months, the net margin was -3.0% for Medical Properties Trust and 63.0% for Simon Property, and the operating margin – and 45.9%. Revenue was $1.0B and $7.2B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.